BioAge discontinues mid-stage trial of obesity drug
BioAge Labs said on Friday it is discontinuing its mid-stage trial studying its experimental drug as a monotherapy and in combination with Eli Lilly's tirzepatide for the treatment of obesity.
The drug developer decided to stop the trial after liver transaminitis, or high levels of certain liver enzymes, were observed in patients receiving the experimental drug, azelaprag.
Tirzepatide is the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound.
The mid-stage trial enrolled about 220 individuals with obesity aged 55 years and older.
Tirzepatide is the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound.
The mid-stage trial enrolled about 220 individuals with obesity aged 55 years and older.
Popular from Business
- 'Doubt on credibility': IndiGo dismisses low ranking in global survey
- India’s first Hyperloop test track is ready! Railway Minister Ashwini Vaishnaw shares exciting update
- Cheer for NRIs! Earn higher interest rates on FCNR(B) deposits till March 31, 2025 - here’s how
- PAN 2.0: Have an extra PAN Card? Surrender now to avoid Rs 10,000 penalty! Check steps
- PAN 2.0 for free! How to get PAN Card with QR code with address update online; step-by-step guide
end of article
Trending Stories
- India’s first Hyperloop test track is ready! Railway Minister Ashwini Vaishnaw shares exciting update
- RBI Monetary Policy Meeting Highlights: Shaktikanta Das-led MPC keeps repo rate unchanged, cuts CRR to 4%; GDP FY25 outlook revised down to 6.6%
- Stock market today: BSE Sensex opens flat ahead of RBI policy; Nifty50 above 24,700
- Why did RBI governor Shaktikanta Das-led MPC not cut repo rate despite GDP shocker? Top 5 points to know
- UPI Lite new rules 2024: RBI increases UPI Lite wallet, transaction limits - here's what UPI users should know
- Airbus cuts over 2,000 jobs amidst competition from Elon Musk's Starlink
- ‘Investing in India is profitable’: Putin heaps praises on PM Modi; says Russia ready to set up manufacturing operations in India
Visual Stories
- NEET UG 2024 result awaited: Top 10 NIRF-ranked medical colleges of India
- 7 New Expected Bullet Train Routes in India
- 10 Upcoming High-Speed Expressways That Will Change Highway Travel In India
- 8 Transformational Indian Railways Projects You Shouldn’t Miss
- Why Sensex, Nifty50 Hit New Highs, M-Cap At $5 Trillion: Top Reasons
UP NEXT
Start a Conversation
Post comment